Hyponatremia causes: Difference between revisions
No edit summary |
|||
(5 intermediate revisions by one other user not shown) | |||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Saeedeh}} | {{CMG}}; {{AE}} {{Saeedeh}} | ||
==Overview== | ==Overview== | ||
Hyponatremia is caused by either increase [[ADH]] action/ secretion or kidney function impairment. [[SIADH|SIAD]] is the most common cause of euvolemic hyponatremia. After SIAD, [[polydipsia]], drugs and clinical disorders are the most encountered etiologies in clinical practice. | Hyponatremia is caused by either increase [[ADH]] action/ secretion or kidney function impairment. [[SIADH|SIAD]] is the most common cause of euvolemic hyponatremia. After [[SIAD]], [[polydipsia]], [[drugs]] and clinical disorders are the most encountered etiologies in clinical practice. | ||
==Causes== | ==Causes== | ||
Line 234: | Line 234: | ||
|- bgcolor="lightsteelblue" | |- bgcolor="lightsteelblue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
| bgcolor="beige" | [[ACE inhibitors]], [[Ajuga nipponensis makino ]] , [[Asenapine maleate]], [[Cefpodoxime]], [[Chlorpropamide]], [[Cyclophosphamide]], [[Desmopressin]], [[Diuretics]], [[Duloxetine]], [[Eslicarbazepine acetate]], [[Ethacrynic Acid]], [[Felbamate]], [[Fluvoxamine]], [[Interferon gamma]], [[Ixabepilone]], [[Losartan and Hydrochlorothiazide]], [[Nilotinib]], [[Nivolumab]], [[Nonsteriodal anti-inflammatory drugs ]] , [[Oxcarbazepine]], [[Pramipexole]], [[Rifaximin]], [[Tiagabine]], [[Tolazamide]], [[Zonisamide]], [[Tolbutamide]], [[Vortioxetine]], [[Brivanib]] <ref name="pmidhttps://www.ncbi.nlm.nih.gov/pubmed/27167519">{{cite journal| author=Berardi R, Santoni M, Rinaldi S, Nunzi E, Smerilli A, Caramanti M | display-authors=etal| title=Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials. | journal=PLoS One | year= 2016 | volume= 11 | issue= 5 | pages= e0152079 | pmid=https://www.ncbi.nlm.nih.gov/pubmed/27167519 | doi=10.1371/journal.pone.0152079 | pmc=4864354 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27167519 }} </ref>, [[Cetuximab]] <ref name="pmidhttps://www.ncbi.nlm.nih.gov/pubmed/27167519">{{cite journal| author=Berardi R, Santoni M, Rinaldi S, Nunzi E, Smerilli A, Caramanti M | display-authors=etal| title=Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials. | journal=PLoS One | year= 2016 | volume= 11 | issue= 5 | pages= e0152079 | pmid=https://www.ncbi.nlm.nih.gov/pubmed/27167519 | doi=10.1371/journal.pone.0152079 | pmc=4864354 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27167519 }} </ref> | | bgcolor="beige" | [[ACE inhibitors]], [[Ajuga nipponensis makino ]] , [[Asenapine maleate]], [[Cefpodoxime]], [[Chlorpropamide]], [[Cyclophosphamide]], [[Desmopressin]], [[Diuretics]], [[Duloxetine]], [[Eslicarbazepine acetate]], [[Ethacrynic Acid]], [[Felbamate]], [[Fluvoxamine]], [[Interferon gamma]], [[Ixabepilone]], [[Losartan and Hydrochlorothiazide]], [[Nilotinib]],[[Nivolumab]]<ref name="HataSakaguchi2021">{{cite journal|last1=Hata|first1=Koichi|last2=Sakaguchi|first2=Chikara|last3=Tsuchiya|first3=Michiko|last4=Nagasaka|first4=Yukio|title=Abdominal pain as an initial symptom of isolated ACTH deficiency induced by nivolumab in a patient with malignant mesothelioma|journal=BMJ Case Reports|volume=14|issue=7|year=2021|pages=e243093|issn=1757-790X|doi=10.1136/bcr-2021-243093}}</ref>, [[Nonsteriodal anti-inflammatory drugs ]] , [[Oxcarbazepine]], [[Pramipexole]], [[Rifaximin]], [[Tiagabine]], [[Tolazamide]], [[Zonisamide]], [[Tolbutamide]], [[Vortioxetine]], [[Brivanib]] <ref name="pmidhttps://www.ncbi.nlm.nih.gov/pubmed/27167519">{{cite journal| author=Berardi R, Santoni M, Rinaldi S, Nunzi E, Smerilli A, Caramanti M | display-authors=etal| title=Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials. | journal=PLoS One | year= 2016 | volume= 11 | issue= 5 | pages= e0152079 | pmid=https://www.ncbi.nlm.nih.gov/pubmed/27167519 | doi=10.1371/journal.pone.0152079 | pmc=4864354 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27167519 }} </ref>, [[Cetuximab]] <ref name="pmidhttps://www.ncbi.nlm.nih.gov/pubmed/27167519">{{cite journal| author=Berardi R, Santoni M, Rinaldi S, Nunzi E, Smerilli A, Caramanti M | display-authors=etal| title=Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials. | journal=PLoS One | year= 2016 | volume= 11 | issue= 5 | pages= e0152079 | pmid=https://www.ncbi.nlm.nih.gov/pubmed/27167519 | doi=10.1371/journal.pone.0152079 | pmc=4864354 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27167519 }} </ref> | ||
|- | |- | ||
|- bgcolor="lightsteelblue" | |- bgcolor="lightsteelblue" | ||
Line 262: | Line 262: | ||
|- bgcolor="lightsteelblue" | |- bgcolor="lightsteelblue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
| bgcolor="beige" | [[After pituitary surgery]], [[After surgery]], [[Ascitic tap]], [[Gastric drainage]], [[Hypotonic infusions]], [[Pleuracentesis]], [[Tumor lysis syndrome]] (TLS associated with pediatric hematologic malignancies, and managed with aggressive intravenous hydration can cause fluid overload (FO) and [[acute kidney injury]] (AKI). <ref name="FloodRozmus2021">{{cite journal|last1=Flood|first1=Kayla|last2=Rozmus|first2=Jacob|last3=Skippen|first3=Peter|last4=Matsell|first4=Douglas G.|last5=Mammen|first5=Cherry|title=Fluid overload and acute kidney injury in children with tumor lysis syndrome|journal=Pediatric Blood & Cancer|year=2021|issn=1545-5009|doi=10.1002/pbc.29255}}</ref> | | bgcolor="beige" | [[After pituitary surgery]], [[After surgery]], [[Ascitic tap]], [[Gastric drainage]], [[Hypotonic infusions]], [[Pleuracentesis]], [[Tumor lysis syndrome]] (TLS) associated with pediatric hematologic malignancies, and managed with aggressive intravenous hydration can cause fluid overload (FO) and [[acute kidney injury]] (AKI). <ref name="FloodRozmus2021">{{cite journal|last1=Flood|first1=Kayla|last2=Rozmus|first2=Jacob|last3=Skippen|first3=Peter|last4=Matsell|first4=Douglas G.|last5=Mammen|first5=Cherry|title=Fluid overload and acute kidney injury in children with tumor lysis syndrome|journal=Pediatric Blood & Cancer|year=2021|issn=1545-5009|doi=10.1002/pbc.29255}}</ref> | ||
|- | |- | ||
Line 275: | Line 275: | ||
|- bgcolor="lightsteelblue" | |- bgcolor="lightsteelblue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
| bgcolor="beige" | [[Intracranial hemorrhage]], [[Subarachnoid hemorrhage]], [[Pituitary cancer]], [[ stroke]] <ref name="pmid31722353">{{cite journal| author=Liamis G, Barkas F, Megapanou E, Christopoulou E, Makri A, Makaritsis K | display-authors=etal| title=Hyponatremia in Acute Stroke Patients: Pathophysiology, Clinical Significance, and Management Options. | journal=Eur Neurol | year= 2019 | volume= 82 | issue= 1-3 | pages= 32-40 | pmid=31722353 | doi=10.1159/000504475 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31722353 }} </ref> | | bgcolor="beige" | [[Intracranial hemorrhage]], [[Subarachnoid hemorrhage]], [[Pituitary cancer]], [[ stroke]] <ref name="pmid31722353">{{cite journal| author=Liamis G, Barkas F, Megapanou E, Christopoulou E, Makri A, Makaritsis K | display-authors=etal| title=Hyponatremia in Acute Stroke Patients: Pathophysiology, Clinical Significance, and Management Options. | journal=Eur Neurol | year= 2019 | volume= 82 | issue= 1-3 | pages= 32-40 | pmid=31722353 | doi=10.1159/000504475 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31722353 }} </ref>, [[Post traumatic brain injury]] [[hypopituitarism]] causing [[adrenal insufficiency]]. <ref name="AwanMat2021">{{cite journal|last1=Awan|first1=Nusrat Mehmood|last2=Mat|first2=Arimin|last3=Canavan|first3=Ronan|title=Retracing the tracks for SIAD: hyponatraemia due to post-traumatic brain injury hypopituitarism|journal=BMJ Case Reports|volume=14|issue=7|year=2021|pages=e242764|issn=1757-790X|doi=10.1136/bcr-2021-242764}}</ref> | ||
|- | |- | ||
|- bgcolor="lightsteelblue" | |- bgcolor="lightsteelblue" | ||
Line 283: | Line 284: | ||
|- bgcolor="lightsteelblue" | |- bgcolor="lightsteelblue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
| bgcolor="beige" | [[Pregnancy]] | | bgcolor="beige" | [[Pregnancy]], postpartum in patients with [[preeclampsia]] <ref name="HsuTong2021">{{cite journal|last1=Hsu|first1=Richard|last2=Tong|first2=Anna|last3=Hsu|first3=Chaur-Dong|last4=Takeuchi|first4=Kyousuke|title=Hypervolemic Hyponatremia as a Reversible Cause of Cardiopulmonary Arrest in a Postpartum Patient with Preeclampsia|journal=Case Reports in Obstetrics and Gynecology|volume=2021|year=2021|pages=1–3|issn=2090-6692|doi=10.1155/2021/8850725}}</ref> | ||
|- | |- | ||
|- bgcolor="lightsteelblue" | |- bgcolor="lightsteelblue" |
Latest revision as of 13:48, 18 August 2021
Hyponatremia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hyponatremia causes On the Web |
American Roentgen Ray Society Images of Hyponatremia causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Saeedeh Kowsarnia M.D.[2]
Overview
Hyponatremia is caused by either increase ADH action/ secretion or kidney function impairment. SIAD is the most common cause of euvolemic hyponatremia. After SIAD, polydipsia, drugs and clinical disorders are the most encountered etiologies in clinical practice.
Causes
To review the mechanisms of developing hyponatremia, click here.
- Etiologies of SIAD:
Conditions | |
---|---|
Malignant disorders | Carcinoma: Lung ( small cell carcinoma, mesothelioma), oropharynx, stomach, duodenum, pancreas, ureter, bladder, prostate, endometrium, thymoma
Lymphomas Sarcomas: Ewing's sarcoma Olfactory neuroblastoma |
Pulmonary diseases | Infections: Bacterial pneumonia, viral pneumonia, pulmonary abscess, tuberculosis, aspergillosis
Others: Asthma, cystic fibrosis, respiratory failure, emphysema, COPD,coronavirus disease, positive-pressure ventilation |
CNS disorders | Infections: Encephalitis, meningitis, brain abscess, RMSF, AIDS, malaria
Vascular and SOP: Subarachnoid hemorrhage, stroke, brain tumors, head trauma Others: Hydrocephalus, cavernous sinus thrombosis, Multiple sclerosis, Guillain–Barré syndrome, Shy–Drager syndrome, delirium tremens, acute intermittent porphyria, chronic psychosis, pituitary stalk section, transsphenoidal adenomectomy |
Other causes | Hereditary: Gain-of-function mutation of V2 receptors
Idiopathic Transient: Exercise, general anesthesia, nausea, pain, stress |
- Causes of acute hyponatremia: (develops in < 48 hrs)
Etiology |
---|
|
( Etiologies that cause hyperacute and acute hyponatremia are applicable to each category interchangeably depending on the onset of symptoms)
- Causes of Hyponatremia based upon Serum Osmolality:
Classification | Serum Osmolality | Etiology |
---|---|---|
Hypertonic or Isotonic Hyponatremia | > 295 mOsm/kg | Hyperglycemia‡, Mannitol, Glycine, Maltose, severe azotemia |
Isotonic Hyponatremia
(Pseudohyponatremia) |
275 – 295 mOsm/kg | Lab/blood draw error, Post TURP (bladder irrigation with osmotic solutions),
intravenous immunoglobulin (IVIg), Hyperlipidemia ( triglyceride, cholesterol ), hyper paraproteinemia (monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma), |
Hypotonic Hyponatremia | < 275 mOsm/kg | Glycerol, Sorbitol, Etiology depends upon volume status (Hypervolemic/ Euvolemic/ Hypovolemic) |
Alcohol, Urea, Ethylen glycol are ineffective osmoles, cause hyperosmolar isotonic serum but not hyponatremia. |
‡ Hyperglycemia causes osmotic diuresis results in a rise in serum sodium concentration, on the other hand it leads to extracellular shift of water due to osmotic gradient which causes relative hyponatremia , depends on which effect is stronger, there would be hypertonicity or hypotonicity[1].
- Causes of Hyponatremia based on volume status [2] :
Volume status | Sodium status | Causes |
---|---|---|
Hypovolemic
Hyponatremia[3] |
|
bicarbonaturia ( renal tubular acidosis, metabolic alkalosis), osmotic diuresis, diuretic use, cerebral salt-wasting syndrome (Stroke ,SAH ,↑ brain natriuretic peptide and ↑ renal sodium loss )
|
Hypervolemic
Hyponatremia |
|
(due to relatively higher water versus salt intake and poor excretion), nephrotic syndrome
|
Euvolemic
Hyponatremia |
|
postoperative nausea, pain, stress, neoplasia (common), trauma, pregnancy) , nephrogenic SIAD (Gain-of-function mutation of v2 receptors)
(caused by a low intake of solutes with relatively high fluid intake)
|
† Altered sensitivity to serum osmolality by the hypothalamic osmoreceptors
- Drugs which cause hyponatremia:
Drug Mechanisms [4] | Drug Classification |
---|---|
Increase ADH secretion | Antidepressants:Tricyclic antidepressants ( Amitryptiline,
Protriptyline, Desipramine),Selective serotonin reuptake inhibitors, Antipsychotic drugs: Phenothiazines (Thioridazine, Trifluoperazine), Antiepileptic drugs: Carbamazepine, Oxcarbazepine, Sodium valproate Anticancer agents: Vinca alkaloids (Vincristine, Vinblastine), Platinum compounds (Cisplatin, Carboplatin) Alkylating agents: Intravenous Cyclophosphamide, Melphalan, Ifosfamide Miscellaneous: Methotrexate, Interferon, Levamisole, Pentostatin, Monoclonal antibodies, MDMA, Nicotine Opiates |
Increase ADH effect | Antiepileptic drugs: Carbamazepine, Lamotrigine
Antidiabetic drugs: Chlorpropamide, Tolbutamide Anticancer agents: Alkylating agents (Intravenous cyclophosphamide) NSAIDS |
Drugs affecting water and sodium homeostasis | Diuretics: Thiazides, Indapamide, Amiloride, Loop diuretics |
Reset omostat ‡ | Antidepressants: Venlafaxine
Antiepileptic drugs: Carbamazepine |
Vasopressin analogues | Desmopressin, oxytocin, terlipressin, vasopressin |
‡ Altered sensitivity to serum osmolality by the hypothalamic osmoreceptors
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ A. I. Arieff & H. J. Carroll (1972). "Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of therapy in 37 cases". Medicine. 51 (2): 73–94. PMID 5013637. Unknown parameter
|month=
ignored (help) - ↑ Guillaumin, Julien; DiBartola, Stephen P. (2017). "A Quick Reference on Hyponatremia". Veterinary Clinics of North America: Small Animal Practice. 47 (2): 213–217. doi:10.1016/j.cvsm.2016.10.003. ISSN 0195-5616.
- ↑ Rondon-Berrios, Helbert; Agaba, Emmanuel I.; Tzamaloukas, Antonios H. (2014). "Hyponatremia: pathophysiology, classification, manifestations and management". International Urology and Nephrology. 46 (11): 2153–2165. doi:10.1007/s11255-014-0839-2. ISSN 0301-1623.
- ↑ Liamis, George; Milionis, Haralampos; Elisaf, Moses (2008). "A Review of Drug-Induced Hyponatremia". American Journal of Kidney Diseases. 52 (1): 144–153. doi:10.1053/j.ajkd.2008.03.004. ISSN 0272-6386.
- ↑ Hata, Koichi; Sakaguchi, Chikara; Tsuchiya, Michiko; Nagasaka, Yukio (2021). "Abdominal pain as an initial symptom of isolated ACTH deficiency induced by nivolumab in a patient with malignant mesothelioma". BMJ Case Reports. 14 (7): e243093. doi:10.1136/bcr-2021-243093. ISSN 1757-790X.
- ↑ 6.0 6.1 Berardi R, Santoni M, Rinaldi S, Nunzi E, Smerilli A, Caramanti M; et al. (2016). "Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials". PLoS One. 11 (5): e0152079. doi:10.1371/journal.pone.0152079. PMC 4864354. PMID https://www.ncbi.nlm.nih.gov/pubmed/27167519 Check
|pmid=
value (help). - ↑ Kim, Dennis Y.; Nassiri, Nariman; de Virgilio, Christian; Ferebee, Michael P.; Kaji, Amy H.; Hamilton, Camille E.; Saltzman, Darin J. (2015). "Association Between Hyponatremia and Complicated Appendicitis". JAMA Surgery. 150 (9): 911. doi:10.1001/jamasurg.2015.1258. ISSN 2168-6254.
- ↑ Flood, Kayla; Rozmus, Jacob; Skippen, Peter; Matsell, Douglas G.; Mammen, Cherry (2021). "Fluid overload and acute kidney injury in children with tumor lysis syndrome". Pediatric Blood & Cancer. doi:10.1002/pbc.29255. ISSN 1545-5009.
- ↑ Królicka AL, Kruczkowska A, Krajewska M, Kusztal MA (2020). "Hyponatremia in Infectious Diseases-A Literature Review". Int J Environ Res Public Health. 17 (15). doi:10.3390/ijerph17155320. PMC 7432506 Check
|pmc=
value (help). PMID 32718076 Check|pmid=
value (help). - ↑ Liamis G, Barkas F, Megapanou E, Christopoulou E, Makri A, Makaritsis K; et al. (2019). "Hyponatremia in Acute Stroke Patients: Pathophysiology, Clinical Significance, and Management Options". Eur Neurol. 82 (1–3): 32–40. doi:10.1159/000504475. PMID 31722353.
- ↑ Awan, Nusrat Mehmood; Mat, Arimin; Canavan, Ronan (2021). "Retracing the tracks for SIAD: hyponatraemia due to post-traumatic brain injury hypopituitarism". BMJ Case Reports. 14 (7): e242764. doi:10.1136/bcr-2021-242764. ISSN 1757-790X.
- ↑ Hsu, Richard; Tong, Anna; Hsu, Chaur-Dong; Takeuchi, Kyousuke (2021). "Hypervolemic Hyponatremia as a Reversible Cause of Cardiopulmonary Arrest in a Postpartum Patient with Preeclampsia". Case Reports in Obstetrics and Gynecology. 2021: 1–3. doi:10.1155/2021/8850725. ISSN 2090-6692.